BENITEC BIOPHARMA INC.
3940 TRUST WAY
HAYWARD, CALIFORNIA 94545
May 29, 2025
VIA EDGAR
Jason Drory
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Benitec Biopharma Inc. |
Registration Statement on Form S-3 (File No. 333-287566)
Dear Mr. Drory:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Benitec Biopharma Inc. hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-287566) so that it may become effective at 4:00 p.m. Eastern Time on June 2, 2025, or as soon thereafter as practicable.
| Very truly yours,
BENITEC BIOPHARMA INC. | ||||
| By: | /s/ Dr. Jerel Banks | |||
| Name: | Dr. Jerel Banks | |||
| Title: | Chief Executive Officer | |||
| cc: | Matt O’Loughlin, Proskauer Rose LLP |
Louis Rambo, Proskauer Rose LLP